Inovio Pharmaceuticals Inc (INO)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Inovio Pharmaceuticals Inc (INO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013846
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA vaccines (immunotherapies) for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. It is advancing a growing preclinical and clinical stage product pipeline to fight cancers of the cervix, prostate, breast, head and neck, lung, and pancreas; and to protect against and eliminate infectious diseases such as HIV, hepatitis, Ebola and Middle East respiratory syndrome (MERS). Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc (INO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inovio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inovio Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Inovio Pharma Acquires Assets from Bioject Medical Technologies for USD5.5 Million 10
Equity Offering 11
Inovio Pharma Prices Public Offering of Shares for USD75 Million 11
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 13
Inovio Pharmaceuticals Inc – Key Competitors 14
Inovio Pharmaceuticals Inc – Key Employees 15
Inovio Pharmaceuticals Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 08, 2017: Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results 18
May 10, 2017: Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results 21
Mar 15, 2017: Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results 23
Nov 09, 2016: Inovio Pharmaceuticals Reports 2016 Third Quarter Financial Results 26
Aug 08, 2016: Inovio Pharmaceuticals Reports 2016 Second Quarter Financial Results 28
May 09, 2016: Inovio Pharmaceuticals Reports 2016 First Quarter Financial Results 30
Mar 14, 2016: Inovio Pharmaceuticals Reports 2015 Fourth Quarter and Year End Financial Results 31
Corporate Communications 34
Jun 28, 2017: Inovio Announces Leadership Appointments 34
Mar 21, 2017: George Bickerstaff Elected to Inovio’s Board of Directors 35
Aug 04, 2016: Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs 36
Mar 11, 2016: Inovio Pharmaceuticals Appoints DNA Immunotherapy Pioneer David B. Weiner, Ph.D., to its Board of Directors 37
Jan 04, 2016: Inovio Pharmaceuticals Adds Dr. Prakash Bhuyan to VGX-3100 Leadership Team for HPV-Related Dysplasia 38
Other Significant Developments 39
Jan 19, 2016: Inovio Pharmaceuticals Awarded Grant to Advance Needle-Free Vaccine Delivery Device 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Inovio Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inovio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inovio Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inovio Pharma Acquires Assets from Bioject Medical Technologies for USD5.5 Million 10
Inovio Pharma Prices Public Offering of Shares for USD75 Million 11
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 13
Inovio Pharmaceuticals Inc, Key Competitors 14
Inovio Pharmaceuticals Inc, Key Employees 15
Inovio Pharmaceuticals Inc, Subsidiaries 17

★海外企業調査レポート[Inovio Pharmaceuticals Inc (INO)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arab International Bank
    Arab International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析
    Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Biosense Webster Inc:企業の製品パイプライン分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Petrel Resources Plc (PET):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrel Resources Plc (Petrel Resources) is an oil and gas company that provides exploration and production of crude oil and natural gas across Iraq. The company provides areas of operations such as Luhais and Subba in Southern Iraq, Tano Basin in Ghana, Porcupine Basin in Ireland, and others …
  • Nanosonics Ltd (NAN)-医療機器分野:企業M&A・提携分析
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Xspray Pharma AB (XSPRAY):製薬・医療:M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • NORDSEE GmbH.:企業の戦略・SWOT・財務情報
    NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report Summary NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析
    Shanghai RAAS Blood Products Co Ltd (002252) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cydan Development Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cydan Development Inc (Cydan) is an orphan drug accelerator dedicated to advancing therapies for rare genetic diseases. The company identifies assets with biology and proof-of-concept data in vivo models from academic circles, industry, and other sources. It offers various technology platfor …
  • Metsa Tissue Corporation:企業の戦略的SWOT分析
    Metsa Tissue Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • RCL Foods Ltd. (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd. (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nihon Medi-Physics Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Nihon Medi-Physics Co Ltd (NMCL), a subsidiary of Sumitomo Chemical Co Ltd, is a radioactive pharmaceuticals and radioactive medical device manufacturer. The company offers research, development, production, sale, purchase and import and export of radioactive pharmaceuticals, medical devices …
  • Banca Monte dei Paschi di Siena S.p.A.:戦略・SWOT・企業財務分析
    Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Monte dei Paschi di Siena S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • China International Water & Electric Corp:企業の戦略的SWOT分析
    China International Water & Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Datron World Communications, Inc.:企業の戦略・SWOT・財務情報
    Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Datron World Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • UniQuest Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • Prana Biotechnology Ltd (PBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Prana Biotechnology Ltd (Prana Biotech) is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease and brain cancer, and other major age-related degenerative disorders. It is developing first-in-class therapies for the treatment of ne …
  • The Home Depot, Inc.:企業の戦略・SWOT・財務情報
    The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Home Depot, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆